COFCO Biotechnology Co (000930.SZ) Stock Price
COFCO Biotechnology Co Price
Over the last 19 years COFCO Biotechnology Co grew revenue by 7.5% annually, reaching 17.51 B CNY. Earnings per share have declined at 1.5% per year over the last 18 years. For COFCO Biotechnology Co, the net margin of 0.2% is down versus 4.8% a few years ago. At today's price the dividend yield works out to roughly 10.98%. The dividend has grown at 23.9% per year over the past 13 years. The consensus 12-month price target for COFCO Biotechnology Co is 12.24 CNY, about 135.8% above where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.
COFCO Biotechnology Co stock price
COFCO Biotechnology Co business model & stock analysis
Frequently asked questions about COFCO Biotechnology Co
Analysts currently set an average price target of 12.24 CNY for the COFCO Biotechnology Co stock (median: 12.24 CNY), implying +135.8 % versus the latest price. The consensus is based on 5 analyst ratings.
5 analysts currently rate the COFCO Biotechnology Co stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect COFCO Biotechnology Co to generate revenue of 16.87 B CNY and earnings per share of -0.10 CNY.
Converted at the current exchange rate, the COFCO Biotechnology Co share trades at 0.69 EUR (5.19 CNY).
The COFCO Biotechnology Co share (000930.SZ) is listed on 1 stock exchanges, including: Shenzhen (000930.SZ).
The expected revenue of COFCO Biotechnology Co is 16.87 B CNY. This figure is based on current financial data and reflects the company's business performance.
The expected profit of COFCO Biotechnology Co is -186.14 M CNY. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of COFCO Biotechnology Co is currently -51.65. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the COFCO Biotechnology Co stock.
The price-to-sales ratio (P/S) of COFCO Biotechnology Co is currently 0.57. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the COFCO Biotechnology Co stock.
The Eulerpool Quality Score for COFCO Biotechnology Co is 3/10.
The ISIN of COFCO Biotechnology Co is CNE000000ZR7. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of COFCO Biotechnology Co is 000930.SZ. The ticker symbol is used to trade COFCO Biotechnology Co shares on the stock exchange.
COFCO Biotechnology Co stock
COFCO Biotechnology Co Peer Group
COFCO Biotechnology Co Ticker
COFCO Biotechnology Co FIGI
All fundamentals and in-depth analysis of COFCO Biotechnology Co
Our stock analysis for COFCO Biotechnology Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of COFCO Biotechnology Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.